Section

Roche Pharma launches Vabysmo to treat vision impairment

By Livemint - 8 months ago
Experts estimate the drug to cost about ₹400,000 in India for the first year of treatment, and ₹200,000 for subsequent years due to lesser dosage requirements

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.